Hikma Pharmaceuticals Plc (HKMPY)
43.94
-0.66
(-1.48%)
USD |
OTCM |
Aug 24, 16:00
Hikma Pharmaceuticals Max Drawdown (5Y) : 64.68% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 64.68% |
| June 30, 2026 | 64.68% |
| May 31, 2026 | 64.68% |
| April 30, 2026 | 64.68% |
| March 31, 2026 | 64.68% |
| February 28, 2026 | 64.68% |
| January 31, 2026 | 64.68% |
| December 31, 2025 | 64.68% |
| November 30, 2025 | 64.68% |
| October 31, 2025 | 64.68% |
| September 30, 2025 | 64.68% |
| August 31, 2025 | 64.68% |
| July 31, 2025 | 64.68% |
| June 30, 2025 | 64.68% |
| May 31, 2025 | 64.68% |
| April 30, 2025 | 64.68% |
| March 31, 2025 | 64.68% |
| February 28, 2025 | 64.68% |
| January 31, 2025 | 64.68% |
| December 31, 2024 | 64.68% |
| November 30, 2024 | 64.68% |
| October 31, 2024 | 64.68% |
| September 30, 2024 | 64.68% |
| August 31, 2024 | 64.68% |
| July 31, 2024 | 64.68% |
| Date | Value |
|---|---|
| June 30, 2024 | 64.68% |
| May 31, 2024 | 64.68% |
| April 30, 2024 | 64.68% |
| March 31, 2024 | 64.68% |
| February 29, 2024 | 64.68% |
| January 31, 2024 | 64.68% |
| December 31, 2023 | 64.68% |
| November 30, 2023 | 64.68% |
| October 31, 2023 | 64.68% |
| September 30, 2023 | 64.68% |
| August 31, 2023 | 64.68% |
| July 31, 2023 | 64.68% |
| June 30, 2023 | 64.68% |
| May 31, 2023 | 64.68% |
| April 30, 2023 | 64.68% |
| March 31, 2023 | 64.68% |
| February 28, 2023 | 67.24% |
| January 31, 2023 | 67.24% |
| December 31, 2022 | 67.24% |
| November 30, 2022 | 67.76% |
| October 31, 2022 | 67.76% |
| September 30, 2022 | 67.76% |
| August 31, 2022 | 67.76% |
| July 31, 2022 | 67.76% |
| June 30, 2022 | 67.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AstraZeneca PLC | 27.87% |
| GSK Plc | 39.39% |
| Allergy Therapeutics Plc | 98.14% |
| Shield Therapeutics Plc | 99.26% |
| Futura Medical Plc | 99.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -17.44 |
| Beta (5Y) | 0.6741 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 33.21% |
| Historical Sharpe Ratio (5Y) | -0.3385 |
| Historical Sortino (5Y) | -0.511 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.55% |